candesartan has been researched along with Arterial Occlusive Diseases in 3 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan treatment normalised the lower part of the autoregulatory curve in SHR, and markedly decreased cerebral ischaemia as a consequence of middle cerebral artery occlusion with reperfusion." | 1.31 | Pre-treatment with candesartan protects from cerebral ischaemia. ( Ito, T; Nishimura, Y; Saavedra, J, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamakawa, H | 1 |
| Jezova, M | 1 |
| Ando, H | 1 |
| Saavedra, JM | 1 |
| Ito, T | 1 |
| Nishimura, Y | 1 |
| Saavedra, J | 1 |
| Sandgaard, NC | 1 |
| Andersen, JL | 1 |
| Holstein-Rathlou, NH | 1 |
| Bie, P | 1 |
3 other studies available for candesartan and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arterial Occlusive Diseases; Ben | 2003 |
Pre-treatment with candesartan protects from cerebral ischaemia.
Topics: Angiotensin Receptor Antagonists; Animals; Arterial Occlusive Diseases; Benzimidazoles; Biphenyl Com | 2001 |
Aortic blood flow subtraction: an alternative method for measuring total renal blood flow in conscious dogs.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta, Abdominal; Arterial Occlusive Diseases; Ben | 2002 |